Genome Rx Insight
Genome Rx Insight
Medication is not one‑size‑fits‑all. GenomeRx Insight analyzes key pharmacogenomic variants that influence how you process many commonly prescribed drugs. Use these insights with your provider to reduce trial‑and‑error, minimize side effects, and move toward more effective, personalized treatment. Simple cheek swab collection. Results delivered securely in the Boomerang Kits App.
This panel provides a comprehensive pharmacogenomic (PGx) analysis of the key genes that govern how your body metabolizes medications — including CYP2D6, CYP2C19, CYP2C9, and related drug-processing genes.
These enzymes metabolize a large proportion of commonly prescribed drugs. Your genetic variants determine whether you're a poor metabolizer (drugs accumulate, increasing side-effect risk) or an ultra-rapid metabolizer (drugs clear too fast, reducing therapeutic effect). Results are formatted for direct sharing with your prescribing clinician.
Medication responses are not one-size-fits-all. The GenomeRx Insight panel provides a comprehensive PGx analysis to help guide treatment decisions across multiple therapeutic areas — including pain management, mental health, cardiovascular, and more. With physician-guided interpretation, you can optimize therapy, reduce side effects, and ensure safer outcomes.
Drug metabolism genes
CYP2D6, CYP2C19, CYP2C9
Adverse reaction risk
Drug sensitivity
Medication classes
Mental health, pain, cardiology
Clinician-ready
FDA-recognized biomarkers
- You are starting a new medication and want to understand how your genes will affect your response (CPIC Guidelines 2023 — CYP2D6 and CYP2C19 genotyping is recommended before prescribing multiple common drug classes.)
- You have experienced unexpected side effects or found that medications don't work as expected (Relling MV & Evans WE, Nature 2015 — up to 25% of patients are poor or ultra-rapid metabolizers at key CYP enzymes, explaining atypical drug responses.)
- You take medications for mental health, pain, cardiovascular conditions, or other chronic conditions (FDA Table of Pharmacogenomic Biomarkers — CYP2D6 and CYP2C19 appear on FDA labels for 100+ approved drugs.)
- Your provider has suggested pharmacogenomic testing before prescribing (CPIC — pre-emptive PGx testing reduces adverse drug events and improves prescribing accuracy.)
- You want to share genetic drug metabolism data with your prescribing physician to guide safer, more effective treatment (Dunnenberger HM et al., Annu Rev Pharmacol Toxicol 2015 — PGx data integrated into EHRs demonstrably reduces ADEs.)
- You want to test once and have this data available for any future medication decisions (Mayo Clinic Right Drug Right Dose Right Patient Program — PGx results are clinically stable over a lifetime and only need to be tested once.)
Key Benefits
Genome Rx Insight · Pharmacogenomic Analysis · Cheek Swab Collection
Frequently Asked Questions
What's included, how to collect, when you'll see results, and how to use them.
What does this panel measure?
A comprehensive pharmacogenomic (PGx) analysis examining how your genes affect drug metabolism and response across multiple therapeutic areas. It identifies potential inefficacies or adverse reactions to support safer, more effective treatment decisions.
How is this different from traditional testing?
GenomeRx Insight combines advanced genomic sequencing with CLIA-certified precision and secure digital delivery. It transforms complex pharmacogenomic data into actionable insights that empower collaboration between patients and clinicians—without clinic visits or hidden telehealth upsells.
Who benefits most from this panel?
Individuals taking multiple prescriptions, experiencing side effects, or seeking to personalize treatment strategies through precision medicine.
How should I use these results?
Review your GenomeRx Insight findings with your healthcare provider to optimize therapy and medication safety. Genetic results should always be interpreted within your overall medical context.
Is this a diagnostic test?
No. This is a genomic screening intended for informational purposes. Genetic results reflect predispositions, not guarantees. Environmental and lifestyle factors also influence outcomes.
How do I collect the sample?
Simple at-home buccal (cheek) swab collection. Follow the insert or in-app guide; it takes only minutes. Place the swab in the provided transport tube, seal securely, and return it using the prepaid mailer.
How do I return my sample?
Use the prepaid mailer included with your kit. Drop it at any postal location the same day you collect your sample to ensure prompt delivery.
What if my sample can't be processed?
If your sample is insufficient or cannot be analyzed, you'll be notified and sent a complimentary replacement kit at no cost.
How long until I see my results?
Typically within 24–48 hours after our laboratory receives your sample, you'll receive a secure notification in the Boomerang Kits App.
Where do I view my results?
Your results are delivered digitally and securely in your Boomerang Kits App, accessible only to you through your personalized login.
Is my data private?
Your genomic data is encrypted, HIPAA-compliant, and never shared without your explicit consent. Boomerang Laboratories maintains the highest standards of data protection and privacy in compliance with all applicable U.S. privacy laws.
Is this covered by insurance?
Boomerang Kits are consumer-initiated and not typically billed to insurance. HSA/FSA funds may apply depending on your plan.
What other panels complement this one?
Mental Health Genomic and ADHD Genomic Panels for a unified view of medication response and neurochemical balance.
What does this panel measure?
A comprehensive pharmacogenomic (PGx) analysis examining how your genes affect drug metabolism and response across multiple therapeutic areas. It identifies potential inefficacies or adverse reactions to support safer, more effective treatment decisions.
How is this different from traditional testing?
GenomeRx Insight combines advanced genomic sequencing with CLIA-certified precision and secure digital delivery. It transforms complex pharmacogenomic data into actionable insights that empower collaboration between patients and clinicians—without clinic visits or hidden telehealth upsells.
Who benefits most from this panel?
Individuals taking multiple prescriptions, experiencing side effects, or seeking to personalize treatment strategies through precision medicine.
How should I use these results?
Review your GenomeRx Insight findings with your healthcare provider to optimize therapy and medication safety. Genetic results should always be interpreted within your overall medical context.
Is this a diagnostic test?
No. This is a genomic screening intended for informational purposes. Genetic results reflect predispositions, not guarantees. Environmental and lifestyle factors also influence outcomes.
How do I collect the sample?
Simple at-home buccal (cheek) swab collection. Follow the insert or in-app guide; it takes only minutes. Place the swab in the provided transport tube, seal securely, and return it using the prepaid mailer.
How do I return my sample?
Use the prepaid mailer included with your kit. Drop it at any postal location the same day you collect your sample to ensure prompt delivery.
What if my sample can't be processed?
If your sample is insufficient or cannot be analyzed, you'll be notified and sent a complimentary replacement kit at no cost.
How long until I see my results?
Typically within 24–48 hours after our laboratory receives your sample, you'll receive a secure notification in the Boomerang Kits App.
Where do I view my results?
Your results are delivered digitally and securely in your Boomerang Kits App, accessible only to you through your personalized login.
Is my data private?
Your genomic data is encrypted, HIPAA-compliant, and never shared without your explicit consent. Boomerang Laboratories maintains the highest standards of data protection and privacy in compliance with all applicable U.S. privacy laws.
Is this covered by insurance?
Boomerang Kits are consumer-initiated and not typically billed to insurance. HSA/FSA funds may apply depending on your plan.
What other panels complement this one?
Mental Health Genomic and ADHD Genomic Panels for a unified view of medication response and neurochemical balance.
